Literature DB >> 14665956

Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells.

Kirsten Bouchelouche1, Susana Alvarez, Lisa Andersen, Jørgen Nordling, Thomas Horn, Pierre Bouchelouche.   

Abstract

PURPOSE: Most recently attention has turned to the secretory properties of smooth muscle cells. Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that causes mast cells recruitment and provokes mast cells activation in vitro. We investigated whether MCP-1 is produced by human detrusor smooth muscle cells (HDSMCs) cultured under inflammatory conditions.
MATERIALS AND METHODS: Using an explantation technique HDSMCs were isolated and short-term cultured. HDSMCs were incubated at 37C for 24 hours with the proinflammatory mediators interleukin-1 beta (IL-1 beta), tumor necrosis factor (TNF-alpha), lipopolysaccharide, histamine, leukotriene D4 and prostaglandin E2. The level of MCP-1 in cell supernatants were measured by enzyme linked immunoassay.
RESULTS: There was basal secretion of MCP-1 in unstimulated cultures. Following 24-hour incubation with IL-1 beta or TNF-alpha (1 pg/ml to 100 ng/ml) the level of MCP-1 increased in a dose dependent manner. IL-1 beta was more potent at inducing MCP-1 release in 8 of 10 experiments. Lipopolysaccharide (10 microg/ml), histamine (100 microM), leukotriene D4 (50 nM), prostaglandin E2 (1 microM) and KCl (30 to 100 mM) failed to induce MCP-1 production. When IL-1 beta (10 ng/ml) and TNF-alpha (10 ng/ml) were given in combination, a highly synergistic effect on MCP-1 production was observed.
CONCLUSIONS: To our knowledge this study shows for the first time that human detrusor smooth muscle cells cultivated under inflammatory conditions produce significant amounts of MCP-1. In addition to contractile function, HDSMCs have synthesis and secretory potential with the release of MCP-1. Thus, MCP-1 may contribute to the local inflammatory process by producing proinflammatory mediators. The release of cytokines and chemokines by human detrusor muscle even in small amounts may have important functional consequences.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14665956     DOI: 10.1097/01.ju.0000090192.36436.d5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.

Authors:  Y Luo; X Chen; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.

Authors:  Anthony T Corcoran; Naoki Yoshimura; Vikas Tyagi; Bruce Jacobs; Wendy Leng; Pradeep Tyagi
Journal:  World J Urol       Date:  2012-03-24       Impact factor: 4.226

3.  Differential profile analysis of urinary cytokines in patients with overactive bladder.

Authors:  Gamal Ghoniem; Nuzhat Faruqui; Mostafa Elmissiry; Ayman Mahdy; Hassan Abdelwahab; Mathew Oommen; Asim B Abdel-Mageed
Journal:  Int Urogynecol J       Date:  2011-04-13       Impact factor: 2.894

4.  Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.

Authors:  Pradeep Tyagi; Saundra S Motley; Mahendra Kashyap; Subrata Pore; Jeffrey Gingrich; Zhou Wang; Naoki Yoshimura; Jay H Fowke
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

5.  Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis.

Authors:  Pradeep Tyagi; Kim Killinger; Vikas Tyagi; Jayabalan Nirmal; Michael Chancellor; Kenneth M Peters
Journal:  J Urol       Date:  2012-04-13       Impact factor: 7.450

6.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

7.  Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study.

Authors:  Pradeep Tyagi; Derek Barclay; Ruben Zamora; Naoki Yoshimura; Kenneth Peters; Yoram Vodovotz; Michael Chancellor
Journal:  Int Urol Nephrol       Date:  2009-09-26       Impact factor: 2.370

8.  Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.

Authors:  Akira Furuta; Tokunori Yamamoto; Yasuyuki Suzuki; Momokazu Gotoh; Shin Egawa; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2018-01-25       Impact factor: 2.894

Review 9.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.